India to Congo: Artemether Export Trade Route
India has recorded 484 verified shipments of Artemether exported to Congo, representing a combined trade value of $20.6M USD. This corridor is served by 77 active Indian exporters, with an average shipment value of $42.5K USD. The leading Indian exporter is MACLEODS PHARMACEUTICALS LTD, which accounts for 55% of total export value with 29 shipments worth $11.3M USD. On the buying side, SECRETARIAT GENERAL DE LA SANTE is the largest importer in Congo with $11.5M USD in purchases. The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, IPCA LABORATORIES LIMITED, BIOMATRIX HEALTHCARE PRIVATE LIMITED — together control 71% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Congo Artemether corridor is one of India's established pharmaceutical export routes, with 484 shipments documented worth a combined $20.6M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's artemether manufacturing sector.
Across 77 active suppliers, the average shipment value stands at $42.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with artemether's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 9.4%, placing it at rank #8 among India's top artemether export destinations globally.
On the import side, key buyers of Indian artemether in Congo include SECRETARIAT GENERAL DE LA SANTE, UNIQUE PHARMA, UNIQUE PHARMA, and 105 others. SECRETARIAT GENERAL DE LA SANTE is the single largest importer with 7 shipments valued at $11.5M USD.
